Teva Pharmaceutical Finance Netherlands III B.V.
Indicative
Full Lot
Indicative price as of 15 Apr 2024, 12:00am
Bond Issuer
Teva Pharmaceutical Finance Netherlands III B.V.
Guarantor
Teva Pharmaceutical Industries Ltd
Announcement Date
19 Apr 2018
Issue Date
17 May 2018
Maturity Date
15 Apr 2024
Years to Maturity / Next Call
- / -
Modified Duration
-
Issue / Reoffer Price
100.000
Issue / Reoffer Yield
5.996165
Coupon Type
Fixed
Annual Coupon Rate
6.000
Coupon Frequency
Semi Annually
Seniority
Senior Unsecured
Reference Rate
-
ISIN
US88167AAL52
CUSIP
88167AAL5
Bond Currency
USD
Total Issue Size
1,248,206,000
Outstanding Issue Size
955,593,000
Min. Investment Quantity (Nominal)
USD 200,000
Incremental Quantity (Nominal)
USD 1,000
Bond Type
High Yield Corporate
Bond Sector
Health Care
Bond Sub Sector
Pharmaceuticals
Issuer Credit Rating (S&P/ Fitch)
***/ N.R
Bond Credit Rating (S&P/ Fitch)
***/ BB-
Shariah Compliant
No
Exchange Listed
Others
“Par Call Date” means (i) with respect to the 2024 notes, January 15, 2024 (the date that is three months prior to the maturity date of such notes) and (ii) with respect to the 2028 notes, December 1, 2027 (the date that is three months prior to the maturity date of such notes).
